Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15
Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $13 to $15.
Stocks · News reference
Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call
LifeStance Health Gr (NASDAQ:LFST) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — LifeStance Health Group, Inc. (LFST)
Filed: 2026-09-11 AccNo: 0001193125-26-389315 Size: 424 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Barclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15
Barclays analyst Peter Warendorf maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $13 to $15.